Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine

J. Bellmunt, J. Albanell, L. Paz-Ares, M.A. Climent, J.L. González-Larriba, J.J. de la Cruz, V. Guillem, E. Díaz-Rubio, H. Cortés-Funes, J.(HVH) Baselga, Joan Carles Galceran

Research output: Contribution to journalArticleResearch

114 Citations (Scopus)
Original languageEnglish
Pages (from-to)751-757
JournalCancer
Volume95
Issue number4
Publication statusPublished - 1 Aug 2002

Cite this